Also, we found that CAF2 up-regulated Wnt signaling pathway genes such WNT2 and WNT5A while down-regulating the expression of Wnt signaling inhibitor SFRP1, which was consistent with findings from the research on CAFs for gastric cancer [29]. This evidence concerns the gene WNT5A and gastric cancer.